Inimmune Alternatives & Competitors
12 companies similar to Inimmune — Harnessing the immune system to create next generation immunotherapeutics for th...
Companies similar to Inimmune
United Biomedical, Inc. (UBI)
Pioneering the future of healthcare with innovative immunotherapeutics and vaccines for ch...
MacroGenics, Inc.
Developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious disea...
Georgiamune Inc.
Georgiamune is reprogramming immune signaling pathways to redirect the immune system to fi...
858 Therapeutics
Discovering innovative small molecule therapeutics for the treatment of cancer
Rival Readout
Competing with Inimmune? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Telormedix
Pioneering targeted immunity for cancer and autoimmune disease treatment through innovativ...
ImmunOs Therapeutics AG
Novel human immunomodulatory proteins for cancer and autoimmune diseases with a specific r...
Coley Pharmaceutical Group
Empowering the immune system to conquer illnesses and boost vaccine efficacy.
Avenzo Therapeutics
Developing the next generation of oncology therapies for patients
Primmune Therapeutics
Engaging Innate Immunity to Cure Cancer
Dicerna Pharmaceuticals
Pioneering breakthroughs in genetic disorders and liver diseases using RNA interference te...
ISU ABXIS CO.,LTD
ISU ABXIS endeavors in making the future without incurable diseases with Isu’s biotechnolo...
About Inimmune
Inimmune, a pioneering biotechnology startup, is making significant strides in the field of healthcare. Founded in 2016 by veterans of the pharmaceutical industry, the company is dedicated to developing next-generation immunotherapeutics designed to harness the immune system for treating a wide array of diseases. With...
Development of disease-modifying immunotherapies, Innovative vaccine adjuvants, Clinical-stage trials for immunotherapy and vaccines, Collaborative research projects with universities and biotech firms
Patients with allergic rhinitis, Healthcare providers focusing on immunotherapy, Biopharmaceutical companies, Research institutions and universities
Immunotherapeutics, Innate Immunity, Pharmaceuticals, Drug Discovery, Medical Research, Cancer Treatment, Autoimmune Diseases, Allergy Treatment, Medical Technology, Biopharmaceuticals
B2B, B2B2C
Licensing, Project Based, Performance Based
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Inimmune: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Inimmune on 12 Sep 2024. The 12 companies listed here were last checked between 21 Jun 2024 and 23 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.